Company Filing History:
Years Active: 2017
Title: Yoo-Hoi Park: Innovator in Pharmaceutical Chemistry
Introduction
Yoo-Hoi Park is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in the treatment of diabetes mellitus. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Yoo-Hoi Park holds a patent for "Triazolone derivatives or salts thereof and pharmaceutical composition comprising the same." This patent describes a triazolone derivative or its pharmaceutically acceptable salt, along with a process for its preparation. The pharmaceutical composition derived from this compound can effectively activate GPR119, making it a valuable tool for preventing or treating diabetes mellitus. He has 1 patent to his name, reflecting his commitment to advancing medical science.
Career Highlights
Yoo-Hoi Park is currently employed at Yuhan Corporation, a leading pharmaceutical company in South Korea. His role at Yuhan Corporation allows him to collaborate with other talented professionals in the field, contributing to the development of innovative healthcare solutions. His work is characterized by a focus on creating effective treatments that can improve the quality of life for patients.
Collaborations
Throughout his career, Yoo-Hoi Park has worked alongside esteemed colleagues such as Tae-Dong Han and Eun-Hye Jung. These collaborations have fostered a dynamic environment for research and development, enabling the team to push the boundaries of pharmaceutical innovation.
Conclusion
Yoo-Hoi Park is a distinguished inventor whose work in pharmaceutical chemistry has the potential to make a significant impact on diabetes treatment. His innovative spirit and dedication to research exemplify the qualities of a leading inventor in the field.